SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-008228
Filing Date
2018-05-01
Accepted
2018-05-01 10:08:15
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20180331_10q.htm 10-Q 757449
2 EXHIBIT 31.1 ex_111207.htm EX-31.1 13461
3 EXHIBIT 31.2 ex_111208.htm EX-31.2 13413
4 EXHIBIT 32 ex_111209.htm EX-32 5740
11 ex_111209img002.gif GRAPHIC 807
12 ex_111208img002.gif GRAPHIC 807
13 ex_111207img002.gif GRAPHIC 807
  Complete submission text file 0001437749-18-008228.txt   3325870

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxfd-20180331.xml EX-101.INS 604558
6 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20180331.xsd EX-101.SCH 38643
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20180331_cal.xml EX-101.CAL 40194
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20180331_def.xml EX-101.DEF 234913
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20180331_lab.xml EX-101.LAB 198753
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20180331_pre.xml EX-101.PRE 257556
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 18793635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances